Reply

Hepatology

Volumn 48, Issue 6, 2008, Pages 2088-

  Fracanzani, Anna Ludovica ^a   Valenti, Luca ^a   Fargion, Silvia ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; DISEASE SEVERITY; FATTY LIVER; GENETIC RISK; GLUCOSE METABOLISM; HEREDITY; HUMAN; INSULIN RESISTANCE; LETTER; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; NONALCOHOLIC FATTY LIVER; PEDIATRICS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 65649106585     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22662     Document Type: Letter

References (4)

1. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. HEPATOLOGY 2008;48:792-798.
2. Manco M, Bedogni G, Marcellini M, Devito R, Ciampalini P, Sartorelli MR, et al. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut 2008;57:1283-1287.
3. Valenti L, Rametta R, Dongiovanni P, Maggioni M, Fracanzani AL, Zappa M, et al. Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis. Diabetes 2008;57:1355-1362.
4. Valverde AM, Fabregat I, Burks DJ, White MF, Benito M. IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes. HEPATOLOGY 2004;40:1285-1294.